GlassScriptPhysician profile
Nicholas Tiberia
NPI 1649260118
$8,046.37
in general payments reported to CMS, 2019-2025
28 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,676 · 2020: $395 · 2021: $1,130 · 2022: $815 · 2023: $1,217 · 2024: $1,522 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,029.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,072.00 | 2019 | |
| Smith+Nephew, INC. | $943.20 | 2019-2024 | Memofix Super Elastic Nitinol Staple System |
| Orthofix Medical, INC. | $621.50 | 2021-2025 | Physio-Stim, Accelstim |
| Integra Lifesciences Corporation | $462.44 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $392.95 | 2021-2025 | |
| Organogenesis INC. | $371.50 | 2019-2024 | |
| Horizon Therapeutics Plc | $346.09 | 2019-2023 | Krystexxa |
| Kerecis Limited | $328.52 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Stryker Corporation | $310.97 | 2020-2023 | Iconix |
| Kci USA, INC. | $275.74 | 2019-2023 | Activ.A.C., Prevena, V.A.C. Dermatac |
| Paratek Pharmaceuticals, INC. | $250.76 | 2022-2024 | Nuzyra |
| Amgen INC. | $249.98 | 2025 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $239.02 | 2021 | |
| Innovation Technologies INC | $238.52 | 2021-2023 | Irrisept |
| Sanara Medtech INC. | $219.05 | 2024-2025 | Celleraterx, Celleraterx |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $196.68 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $165.54 | 2024 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Medline Industries LP | $162.96 | 2024 | |
| Zimmer Biomet Holdings, INC. | $161.07 | 2024 | |
| Acera Surgical, INC. | $149.03 | 2023 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $132.00 | 2022 | |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Lifenet Health | $123.53 | 2025 | Theragenesis Wound Matrix |
| Advanced Oxygen Therapy INC. | $122.08 | 2019 | |
| Abbvie INC. | $110.60 | 2022 | |
| Biopoly LLC | $105.00 | 2024 | |
| Melinta Therapeutics, LLC | $97.97 | 2021 | |
| Prodigy Surgical Distribution, INC. | $72.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Tiberia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.